# Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile
> **Food and Drug Administration** · Final rule. · Published 2012-02-06 · Effective 2012-02-06 · 77 FR 5696
## Document
- **Document number:** 2012-2558
- **Category:** fda-device
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 77 FR 5696
- **CFR reference:** 21 CFR 201
- **Publication date:** 2012-02-06
- **Effective date:** 2012-02-06
- **HHS docket:** Docket No. FDA-2006-N-0364
## Abstract

The Food and Drug Administration (FDA) is adopting as a final rule, without change, the interim final rule that issued regulations permitting FDA Center Directors to grant exceptions or alternatives to certain regulatory labeling requirements applicable to human drugs, biological products, or medical devices that are or will be included in the Strategic National Stockpile (SNS). FDA is taking this action to complete the rulemaking initiated with the interim final rule.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2012/02/06/2012-2558/exceptions-or-alternatives-to-labeling-requirements-for-products-held-by-the-strategic-national)
---
*AI Analytics · CC0 1.0*